Efficacy of infliximab for disc herniation-induced sciatica: one-year follow-up.
Korhonen
Timo
T
Department of Physical Medicine and Rehabilitation, Oulu University Hospital, Oulu, Finland.
Karppinen
Jaro
J
Malmivaara
Antti
A
Autio
Reijo
R
Niinimäki
Jaakko
J
Paimela
Leena
L
Kyllönen
Eero
E
Lindgren
Karl-August
KA
Tervonen
Osmo
O
Seitsalo
Seppo
S
Hurri
Heikki
H
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D007405:Intervertebral Disc Displacement / Q000150:complications*; D007866:Leg / Q000473:pathology; D008297:Male; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D012585:Sciatica / Q000188:drug therapy* / Q000209:etiology*; D013995:Time; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab